Home LiteratureArticle Details
PMID: 12608703 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

The induction of the TNFalpha death domain signaling pathway in Alzheimer's disease brain.

Neurochemical research ·Vol. 28 ·No. 2 ·2003-02-00 ·Pages 307-18

Zhao M, Cribbs DH, Anderson AJ, Cummings BJ, Su JH, Wasserman AJ, Cotman CW

Abstract

The tumor necrosis factor-alpha death domain pathway contributes to cellular degeneration in a variety of conditions. This study investigates the hypothesis that this death domain pathway is progressively induced in the brain during the progression of Alzheimer's disease (AD). AD cases had increased levels of proapoptotic markers including tumor necrosis factor-alpha (TNFalpha), TNF receptor type 1 (TNF-R1), TNF receptor-associated death domain (TRADD), and caspase-3, 2- to 10-fold higher (P < .01) than age-matched controls and 1 to 3 times higher than transitional cases. In striking contrast, potentially neuroprotective TNF receptor type 2 (TNF-R2), and Fas-associated death domain-like interleukin-1beta-converting enzyme (FLICE) inhibitor protein (FLIP) were decreased in AD as compared with age-matched control cases (P < .01). Overall, there was an elevation in proapoptotic elements, including a 5-fold increase in TNF-R1 and a 12-fold decrease in FLIP in AD brains. These changes may translate to increased degenerative potential because the downstream effector caspase-3 and product of the TNF pathway was also increased in parallel with enhanced TNF proapoptotic conditions. Our findings suggest that the TNF death receptor pathway and caspases are activated in the early stages of neuronal degeneration in AD.

MeSH Terms
Alzheimer Disease/metabolism,pathology Brain/metabolism,pathology Humans Immunohistochemistry Proteins/metabolism Signal Transduction TNF Receptor-Associated Factor 1
Chemicals
Proteins TNF Receptor-Associated Factor 1
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Zhao Ming
Institute for Brain Aging and Dementia, University of California Irvine, Irvine, California, USA.
Cribbs David H
Anderson Aileen J
Cummings Brian J
Su Joseph H
Wasserman Andrea J
Cotman Carl W
References (48)
48 references, click to expand
  1. Signalling by CD95 and TNF receptors: not only life and death.
    Immunol Cell Biol. 1999 Feb;77(1):41-6 PMID: 10101685
  2. Neuronal apoptosis induced by beta-amyloid is mediated by caspase-8.
    Neurobiol Dis. 1999 Oct;6(5):440-9 PMID: 10527810
  3. Bcl-2 expression regulates cell sensitivity to S100beta-mediated apoptosis.
    Brain Res Mol Brain Res. 1999 Jun 18;70(1):167-76 PMID: 10381557
  4. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains.
    Science. 1999 Jan 22;283(5401):543-6 PMID: 9915703
  5. Diagnosis of Alzheimer's disease.
    Arch Neurol. 1985 Nov;42(11):1097-105 PMID: 2864910
  6. A high plasma concentration of TNF-alpha is associated with dementia in centenarians.
    J Gerontol A Biol Sci Med Sci. 1999 Jul;54(7):M357-64 PMID: 10462168
  7. A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide.
    Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9879-84 PMID: 10449788
  8. Inflammatory markers in younger vs elderly normal volunteers and in patients with Alzheimer's disease.
    J Psychiatr Res. 1999 Sep-Oct;33(5):397-405 PMID: 10504008
  9. Caspases: key mediators of apoptosis.
    Chem Biol. 1998 May;5(5):R97-103 PMID: 9578633
  10. DNA damage and activated caspase-3 expression in neurons and astrocytes: evidence for apoptosis in frontotemporal dementia.
    Exp Neurol. 2000 May;163(1):9-19 PMID: 10785439
  11. Caspases: enemies within.
    Science. 1998 Aug 28;281(5381):1312-6 PMID: 9721091
  12. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis.
    Nature. 1995 Jul 6;376(6535):37-43 PMID: 7596430
  13. The role of c-FLIP in modulation of CD95-induced apoptosis.
    J Biol Chem. 1999 Jan 15;274(3):1541-8 PMID: 9880531
  14. Activation of the CPP32 protease in apoptosis induced by 1-beta-D-arabinofuranosylcytosine and other DNA-damaging agents.
    Blood. 1996 Sep 15;88(6):1936-43 PMID: 8822910
  15. The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region.
    EMBO J. 1992 Apr;11(4):1593-7 PMID: 1563356
  16. Caspases find a new place to hide.
    Nature. 2000 Jan 6;403(6765):29-30 PMID: 10638735
  17. Recent advances on neuronal caspases in development and neurodegeneration.
    Neurochem Int. 1999 Sep;35(3):195-220 PMID: 10458652
  18. Modulation of life and death by the TNF receptor superfamily.
    Oncogene. 1998 Dec 24;17(25):3261-70 PMID: 9916988
  19. Neuropathological stageing of Alzheimer-related changes.
    Acta Neuropathol. 1991;82(4):239-59 PMID: 1759558
  20. Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia.
    J Clin Immunol. 1999 Jul;19(4):223-30 PMID: 10471976
  21. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation.
    Cell. 1999 Apr 30;97(3):395-406 PMID: 10319819
  22. Cleavage of CPP32 by granzyme B represents a critical role for granzyme B in the induction of target cell DNA fragmentation.
    J Biol Chem. 1996 Sep 6;271(36):21709-12 PMID: 8702964
  23. Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis.
    J Neurosci. 1998 Sep 15;18(18):7061-74 PMID: 9736630
  24. Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia.
    Mol Med. 1997 Nov;3(11):765-81 PMID: 9407552
  25. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis.
    Neuron. 1994 Jan;12(1):139-53 PMID: 7507336
  26. Cytokines and the nervous system. I: Expression and recognition.
    Trends Neurosci. 1995 Feb;18(2):83-8 PMID: 7537419
  27. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.
    Cell. 1996 Jan 26;84(2):299-308 PMID: 8565075
  28. In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system.
    Cell Death Differ. 1998 Dec;5(12):1004-16 PMID: 9894607
  29. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.
    Neurology. 1991 Apr;41(4):479-86 PMID: 2011243
  30. A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor.
    Nat Med. 2000 Apr;6(4):397-404 PMID: 10742146
  31. Apoptosis control by death and decoy receptors.
    Curr Opin Cell Biol. 1999 Apr;11(2):255-60 PMID: 10209153
  32. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death.
    Science. 1993 Jan 29;259(5095):689-92 PMID: 8430320
  33. Inhibition of fas death signals by FLIPs.
    Curr Opin Immunol. 1998 Oct;10(5):552-8 PMID: 9794838
  34. Immunohistochemical evidence for apoptosis in Alzheimer's disease.
    Neuroreport. 1994 Dec 20;5(18):2529-33 PMID: 7696596
  35. Programmed cell death of embryonic motoneurons triggered through the Fas death receptor.
    J Cell Biol. 1999 Nov 29;147(5):1049-62 PMID: 10579724
  36. Beta-amyloid induces local neurite degeneration in cultured hippocampal neurons: evidence for neuritic apoptosis.
    Neurobiol Dis. 1998 Nov;5(5):365-78 PMID: 10069579
  37. Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer's disease.
    J Biol Chem. 1999 Aug 13;274(33):23426-36 PMID: 10438520
  38. Transducers of life and death: TNF receptor superfamily and associated proteins.
    Oncogene. 1996 Jan 4;12(1):1-9 PMID: 8552378
  39. Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures.
    Dev Neurosci. 1994;16(3-4):172-9 PMID: 7705222
  40. Optimization of techniques for the maximal detection and quantification of Alzheimer's-related neuropathology with digital imaging.
    Neurobiol Aging. 2002 Mar-Apr;23(2):161-70 PMID: 11804699
  41. Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation.
    Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9328-32 PMID: 7568127
  42. Targeted disruption of caspase genes in mice: what they tell us about the functions of individual caspases in apoptosis.
    Immunol Cell Biol. 1999 Feb;77(1):58-63 PMID: 10101687
  43. Increased TNF-alpha-induced apoptosis in lymphocytes from aged humans: changes in TNF-alpha receptor expression and activation of caspases.
    J Immunol. 1999 Feb 15;162(4):2154-61 PMID: 9973490
  44. Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35.
    Neuroreport. 1993 May;4(5):523-6 PMID: 8513131
  45. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding.
    Neuron. 1993 Jun;10(6):1089-99 PMID: 8318230
  46. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons.
    Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):7951-5 PMID: 8367446
  47. Death receptors: signaling and modulation.
    Science. 1998 Aug 28;281(5381):1305-8 PMID: 9721089
  48. Caspases: the executioners of apoptosis.
    Biochem J. 1997 Aug 15;326 ( Pt 1):1-16 PMID: 9337844
Article Info
Journal
Neurochemical research
Abbr.
Neurochem Res
ISSN
0364-3190
Published
2003-02-00
Pages
307-18
Language
English
Region
United States
NLM ID
7613461
Subset
IM
Grants
NIA NIH HHS · AG00538 · United States
NIA NIH HHS · AG17765 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com